Literature DB >> 20080475

Id-1 expression and prognosis in cancer: do antibodies matter?

Ignacio Gil-Bazo, Mariano Ponz-Sarvisé, Angel Panizo-Santos, Alfonso Calvo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20080475     DOI： 10.1007/s12094-010-0470-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  12 in total

1.  Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells.

Authors:  Vladimir Jankovic; Alessia Ciarrocchi; Piernicola Boccuni; Tony DeBlasio; Robert Benezra; Stephen D Nimer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

2.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

3.  The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells.

Authors:  Jau-Chen Lin; Sun-Yran Chang; Dar-Shih Hsieh; Chi-Feng Lee; Dah-Shyong Yu
Journal:  Oncol Rep       Date:  2005-05       Impact factor: 3.906

4.  Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway.

Authors:  Xue Song Ouyang; Xianghong Wang; Ming-Tat Ling; Hing Lok Wong; Sai Wah Tsao; Y C Wong
Journal:  Carcinogenesis       Date:  2002-05       Impact factor: 4.944

5.  Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody.

Authors:  Jonathan Perk; Ignacio Gil-Bazo; Yvette Chin; Paola de Candia; John J S Chen; Yuntao Zhao; Shirley Chao; Wai Cheong; Yaohuang Ke; Hikmat Al-Ahmadie; William L Gerald; Edi Brogi; Robert Benezra
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

Review 6.  Angiogenesis and ovarian cancer.

Authors:  César Gómez-Raposo; Marta Mendiola; Jorge Barriuso; Enrique Casado; David Hardisson; Andrés Redondo
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

7.  Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.

Authors:  Monika Schindl; Sebastian F Schoppmann; Thomas Ströbel; Harald Heinzl; Christina Leisser; Reinhard Horvat; Peter Birner
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

8.  ID genes mediate tumor reinitiation during breast cancer lung metastasis.

Authors:  Gaorav P Gupta; Jonathan Perk; Swarnali Acharyya; Paola de Candia; Vivek Mittal; Katia Todorova-Manova; William L Gerald; Edi Brogi; Robert Benezra; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-28       Impact factor: 11.205

9.  Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors.

Authors:  Paola de Candia; David B Solit; Dilip Giri; Edi Brogi; Peter M Siegel; Adam B Olshen; William J Muller; Neal Rosen; Robert Benezra
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-02       Impact factor: 11.205

10.  Id-1 is not expressed in the luminal epithelial cells of mammary glands.

Authors:  Norihisa Uehara; Yu-Chien Chou; Jose J Galvez; Paola de-Candia; Robert D Cardiff; Robert Benezra; Gopalan Shyamala
Journal:  Breast Cancer Res       Date:  2003-01-09       Impact factor: 6.466
View more
  1 in total

1.  Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium.

Authors:  Fang Hao; Marybeth A Pysz; Kathryn J Curry; Kristin N Haas; Steven J Seedhouse; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.